NCT04093570 2025-10-31
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Taiho Oncology, Inc.
Phase 2 Enrolling by invitation
Taiho Oncology, Inc.
Pediatric Transplantation & Cellular Therapy Consortium
Pediatric Transplantation & Cellular Therapy Consortium